See every side of every news story
Published loading...Updated

Latest News TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant - Businessfortnight

Summary by Businessfortnight
TAIPEI, Feb. 17, 2025 /PRNewswire/ — TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world’s first Apixaban oral dissolving film (ODF). The study confirmed that TAH3311 is bioequivalent to U.S. and European reference Apixaban tablets (Eliquis®) under fasting conditions, with Cmax and AUC values falling within the regulatory acceptance range (80-125%). The study enrolled 60 healthy volunteers wit…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Businessfortnight broke the news in on Monday, February 17, 2025.
Sources are mostly out of (0)